Avid Bioservices(CDMO) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Avid Bioservices Reports Financial Results for First Quarter Ended July 31, 2024 -- Recorded First Quarter Revenue of $40.2 Million -- -- Signed$66 Million in Net New Business, Resulting in Backlog of $219 Million -- -- Maintained FY2025 Revenue Guidance of Between$160 Million and $168 Million -- TUSTIN, Calif., September 9, 2024 -- Avid Bioservices, Inc. (NASDAQ: CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by provid ...